Search for Clinical Trial Results
Amyloidosis - 257 Studies Found
Status | Study |
Not yet recruiting |
Study Name: Ibrutinib With or Without Bortezomib and Dexamethasone in Treating Patients With Relapsed or Refractory Immunoglobulin Light Chain Amyloidosis Condition:
Date: 2017-04-21 Interventions:
|
Recruiting |
Study Name: Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis Condition: Relapsed or Refractory Systemic Light Chain Amyloidosis Date: 2012-08-02 Interventions:
|
Recruiting |
Study Name: The VITAL Amyloidosis Study, a Global Phase 3, Efficacy and Safety Study of NEOD001 in Patients With AL Amyloidosis Condition: Primary Systemic (AL) Amyloidosis Date: 2014-12-02 Interventions:
|
Completed |
Study Name: Risk-adapted Therapy for Primary Systemic (AL) Amyloidosis Condition: Amyloidosis Date: 2011-07-28 Interventions: Drug: melphalan, thalidomide and dexamethasone |
Completed |
Study Name: Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden Condition:
Date: 2008-03-31 Interventions:
|
Recruiting |
Study Name: Collecting Samples From Patients With Primary Systemic Amyloidosis Condition: Multiple Myeloma Date: 2009-05-09 Interventions:
|
Completed |
Study Name: Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction Condition:
Date: 2007-10-19 Interventions: Biological: Human immune globulin intravenous (IGIV) Analyze the therapeutic potential of human immune g |
Recruiting |
Study Name: Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource Condition:
|
Completed |
Study Name: High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating Patients With Amyloidosis Condition: Multiple Myeloma and Plasma Cell Neoplasm Date: 1999-11-01 Interventions:
|